Quest PharmaTech (TSXV:QPT) 3-Year Dividend Growth Rate : 0.00% (As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech 3-Year Dividend Growth Rate?

Quest PharmaTech's Dividends per Share for the three months ended in Oct. 2023 was C$0.00.

The historical rank and industry rank for Quest PharmaTech's 3-Year Dividend Growth Rate or its related term are showing as below:

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Quest PharmaTech was -2.20% per year. The lowest was -20.60% per year. And the median was -11.40% per year.

TSXV:QPT's 3-Year Dividend Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 13.8
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Quest PharmaTech's Dividend Payout Ratio for the three months ended in Oct. 2023 was 0.00. As of today, Quest PharmaTech's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Quest PharmaTech's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Quest PharmaTech's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quest PharmaTech's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's 3-Year Dividend Growth Rate falls into.

Quest PharmaTech 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Quest PharmaTech (TSXV:QPT) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Quest PharmaTech's Dividend Payout Ratio for the quarter that ended in Oct. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Oct. 2023 )	/	EPS without NRI (Q: Oct. 2023 )
	=	0	/	-0.006
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest PharmaTech 3-Year Dividend Growth Rate Related Terms>

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines